K192239: WavelinQ Plus EndoAVF System (FDA 510(k) & Recall Dossier)

U.S. FDA 510(k) Premarket Notification K192239 (WavelinQ Plus EndoAVF System, cleared 2019-10-17 for C.R. Bard, Inc.) reconciled with CDRH recall records on Predicate Ledger.

Reconciled U.S. FDA 510(k) Premarket Notification Metadata for K192239
Regulatory FieldVerified FDA Record
FDA 510(k) NumberK192239
Cleared Device Trade / Generic NameWavelinQ Plus EndoAVF System
FDA Applicant on FilingC.R. Bard, Inc.
FDA 3-Letter Product ClassificationProduct Code PQK
FDA Substantial Equivalence Decision Date2019-10-17
De-Broadcasted Recall LinkageLinked to at least one historical or open CDRH/openFDA recall notice (1976 to 2026)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Becton, Dickinson and Company (BD) across sibling Meru public-data platforms.

Inspect consolidated manufacturer lineage at C.R. Bard, Inc., compare peer devices under FDA Product Code PQK, or browse all 20 FDA clinical specialties.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.